Memantinhydrochlorid Macleods

Memantine Hydrochloride, the active ingredient in Memantinhydrochlorid Macleods, is an NMDA receptor antagonist presented as a tablet for oral use. It is indicated for the symptomatic treatment of moderate to severe Alzheimer’s disease in adults.

GNH USA supplies Memantinhydrochlorid Macleods as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Memantine Hydrochloride is used in the management of neurodegenerative disorders, specifically Alzheimer’s disease, by modulating glutamatergic neurotransmission.

- Alzheimer’s disease (moderate to severe): improves cognition, functional abilities, and overall daily living activities. - Alzheimer’s disease (behavioral symptoms): may reduce agitation, aggression, and psychosis associated with the disease. - Alzheimer’s disease (disease progression): can help slow functional decline and maintain independence for a longer period.

Memantine Hydrochloride may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Constipation - Confusion - Somnolence - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., rash, Stevens‑Johnson syndrome) - Cardiac arrhythmias - Hepatic dysfunction - Hallucinations or psychosis - Suicidal thoughts or behavior

When prescribing Memantine Hydrochloride, clinicians should consider several precautionary measures to ensure patient safety. - Renal impairment: adjust dose or monitor renal function closely. - Hepatic impairment: use with caution and monitor liver enzymes. - History of seizures: monitor for increased seizure activity. - Concomitant NMDA antagonists: avoid combined use to prevent additive toxicity. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Elderly patients: monitor for confusion, falls, and worsening cognition. - Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Memantine Hydrochloride can interact with other medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Amantadine: combined NMDA antagonism may increase neurotoxicity. - Ketamine: additive NMDA blockade can lead to excessive central nervous system depression. - Other NMDA antagonists (e.g., dextromethorphan): risk of heightened adverse effects.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish cognitive benefits of memantine. - Central nervous system depressants (e.g., benzodiazepines, opioids): may enhance sedation and dizziness. - Diuretics: can affect blood pressure and electrolyte balance. - Antihypertensive drugs: potential additive hypotensive effect.